Navigation Links
XGEVA® (Denosumab) Granted Marketing Authorization in the European Union
Date:7/15/2011

THOUSAND OAKS, Calif., July 15, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the European Commission (EC) has granted marketing authorization for XGEVA® (denosumab) for the prevention of skeletal-related events (SREs) (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with bone metastases from solid tumors. This approval of XGEVA applies to all 27 European Union (EU) member states. The EC also granted XGEVA an additional year of data and market exclusivity in the EU since the indication was considered new for denosumab and based on the significant clinical benefit of XGEVA in comparison with existing therapies.

Bone metastases, the spread of cancer to the bones, are a common and serious concern for patients with advanced cancer and present a burden to the healthcare system. Weakened bones due to metastases can lead to SREs. The primary goal of treatment for bone metastases is to prevent the occurrence of these debilitating and costly SREs.

"Skeletal-related events associated with bone metastases are truly devastating and painful for patients living with cancer, and today's approval of XGEVA marks a real advance," said Professor Ingo J. Diel, M.D., Institute for Gynecological Oncology, SPGO, Mannheim, Germany. "In clinical trials XGEVA demonstrated sustained protection from SREs and also delayed the progression of pain. These factors will make a genuine difference in the lives of patients living with advanced cancer."

The marketing authorization for XGEVA is based on three pivotal, Phase 3 head-to-head trials that evaluated the effectiveness of XGEVA versus zoledronic acid at delaying SREs. The SRE clinical program for XGEVA spanned more than 50 tumor types in over 5,700 patients. In the SRE trials, XGEVA demonstrated a clinically meaningful improvement in preventing SREs compared to zoledronic acid. In these trials, XGEVA was administered every four weeks as a 120 mg subcu
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
2. Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate
3. Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial
4. Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer
5. The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma
6. XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
7. Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
8. Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
9. China Botanic Pharmaceutical Granted China Patent for Siberian Ginseng Extraction Process
10. ACT Granted EU Orphan Medicinal Product Designation for hESC-Derived RPE Cells for Treatment of Stargardts Disease
11. ViroPharmas Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)...  Konica Minolta, Inc. (Konica Minolta) ( Tokyo ... Sawae Technologica Ltda., an X-ray system equipment manufacturer based ... its Brazilian healthcare sales company, Konica Minolta Healthcare do ... Brazil market investment and growth With ... million, significant healthcare technical advancements and efficiencies are required. ...
(Date:7/2/2015)... , South Korea, July 2, 2015 ALPINION ... a new E-CUBE Series ultrasound system. Developed to enhance ... clinical areas, the E-CUBE 15 EX produces superb image ... clinical performance in women,s health, general imaging, and shared ... The latest in the renowned E-CUBE Series, the ...
(Date:7/2/2015)... 2015   Wilson Therapeutics AB , a privately-held ... to its board of directors. The appointment was approved ... June 30. "We are delighted to welcome ... Hansson , CEO of Wilson Therapeutics. "Hans brings significant ... forward to his contributions to the Company." ...
Breaking Medicine Technology:Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3Wilson Therapeutics Appoints Hans Schikan to its Board of Directors 2
... Hill-Rom Holdings, Inc. (NYSE: HRC ) will release ... 2011.  The company will host a webcast the following morning ... Earnings Release:   Hill-Rom,s Fiscal 2011 First Quarter ... be issued to the public after the close of the ...
... Jan. 11, 2011 TREVENTIS Corporation founder, Christopher ... his work in computer-aided drug design.  Dr. Barden ... Awards dinner sponsored by Nova Scotia,s Discovery Centre. ... drug discovery system called the Common Conformational Motif ...
Cached Medicine Technology:Hill-Rom Holdings, Inc. Hosts Fiscal 2011 First Quarter Earnings Webcast 2TREVENTIS Corporation Founder Wins Prestigious Discovery Award 2
(Date:7/2/2015)... ... 2015 , ... Every year, DUI arrests and fatalities spike on the 4th of July. In ... the year when it comes to being on the road. According to attorney David ... that 40% of all highway deaths between 2007 and 2011 were caused by drunk driving ...
(Date:7/2/2015)... ... July 02, 2015 , ... Today, East Liverpool City ... Surgical Center at East Liverpool City Hospital (ELCH). Pam is currently the Chief Nursing ... the director of surgery. Pam holds a master’s degree in health care administration as ...
(Date:7/2/2015)... ... July 02, 2015 , ... It’s no secret that what we consume can have an effect on the body. ... easily feel dehydrated or perhaps even undernourished if not eating enough of the right foods, as ... an easy time of year to overdo it on the food front as well, with sweet ...
(Date:7/2/2015)... ... July 02, 2015 , ... As part of the celebration of its 70th ... gratitude to its patients from all around the world for their continuous patronage of ... off on a dental tour (indeed, Thantakit is one of the foremost places for ...
(Date:7/2/2015)... ... 02, 2015 , ... Cs &A, the leader in Semi ... release and publication of their newest offering to complement the existing line of ... , Designed in support of coverage for the full spectrum of Semi Timing ...
Breaking Medicine News(10 mins):Health News:Attorney David Maloney Stresses Safety through Sobriety 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 3Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:Thailand's Longest Established International Dental Center Celebrates Its 70th Anniversary with Promos Galore 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4
... ROCHESTER, Minn., Dec. 9 Here are highlights from the December ... this publication as often as you wish. Mayo Clinic ... allowed for a fee. Include the following subscription information as your ... subscription information, 800-876-8633, extension 9751. , , ...
... recent poll, Travel Nurse,Source, a premier provider of recruitment marketing ... to assess the state of the,industry in view of the ... are not as plentiful right now, there was also,agreement that ... in,today,s financial climate. , ...
... to women with metastatic or recurrent inoperable disease, report ... the last 35 years, non-hormonal treatments have improved overall ... say Greek researchers who conducted a review of 128 ... the disease. , The review showed that use of ...
... that Clean Energy Will Make Air Healthier to Breathe , ... The American Lung Association, a leader in the fight ... Pickens Plan at a press conference today with Mayor Michael ... leader and philanthropist. Developed by Mr. Pickens, the Pickens Plan ...
... ANTONIO, Dec. 9 The Texas office of Oaks ... II, a 35,000,square-foot medical office building at 3603 Paesanos ... just east of the intersection of Loop 1604 and,Northwest ... divides ownership of the building among the tenants, equity,investors ...
... Danielle and John Centrello decided to bank their baby,s cord blood with ... blood, hoping never to use it, but wanted to have it just ... ... -- While pregnant, Danielle and John Centrello decided to bank their baby,s ...
Cached Medicine News:Health News:December 2008 Mayo Clinic Women's HealthSource Highlights Happiness, Dementia and Smoking 2Health News:December 2008 Mayo Clinic Women's HealthSource Highlights Happiness, Dementia and Smoking 3Health News:December 2008 Mayo Clinic Women's HealthSource Highlights Happiness, Dementia and Smoking 4Health News:December 2008 Mayo Clinic Women's HealthSource Highlights Happiness, Dementia and Smoking 5Health News:Travel Nursing Agencies Stand Up to a Tough Economy 2Health News:Non-Hormonal Therapies Aid Breast Cancer Patients 2Health News:American Lung Association Announces Support of Pickens Plan 2Health News:American Lung Association Announces Support of Pickens Plan 3Health News:American Lung Association Announces Support of Pickens Plan 4Health News:Oaks Development Group Closes on Third San Antonio Project 2Health News:Oaks Development Group Closes on Third San Antonio Project 3Health News:Local Child Treated In Clinical Trial To Ease Symptoms of Cerebral Palsy 2Health News:Local Child Treated In Clinical Trial To Ease Symptoms of Cerebral Palsy 3Health News:Local Child Treated In Clinical Trial To Ease Symptoms of Cerebral Palsy 4
... The Ellex Solitaire represents the latest in ... photocoagulator system for use in both the ... with surgeon preference testing and the most ... world, Solitaire is the premium 532nm photocoagulator ...
... Blinkeze External Lid Weights offer the physician ... the treatment of facial paralysis. The weight simply ... when the patient looks down, or when the ... External Lid Weights in a variety of skin ...
The TOPCON SP-2000P Non -Contact Specular Microscope is a new generation of diagnostic accuracy and versatility in non-contact specular microscopy. The SP-2000P can be linked to TOPCON's IMAGEnet sys...
... This equipment is a ... of mydriatic and non-mydriatic photography ... and 25 (45 and 22 ... record photographic data with 35-mm ...
Medicine Products: